There are murmurs among clinical research industry executives that India's health ministry will reexamine some of the clauses in the rules on compensation in case of clinical trial injury that it had notified in the Gazette of India in February and that had caused grave concern among trial sponsors. This follows discussions between the industry … Continue reading India and clinical trials : no denoument in sight
Apothecurry 